Market Closed -
Hong Kong S.E.
04:08:20 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
0.53
HKD
|
0.00%
|
|
0.00%
|
+9.28%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
145.9
|
152.5
|
147.3
|
138.7
|
107.2
|
94.58
|
Enterprise Value (EV)
1 |
123.6
|
140.1
|
125.2
|
113.3
|
122.5
|
90.94
|
P/E ratio
|
10.2
x
|
9.82
x
|
8.88
x
|
12.7
x
|
-24.5
x
|
13.5
x
|
Yield
|
5.88%
|
6.13%
|
6.78%
|
4.77%
|
-
|
7.39%
|
Capitalization / Revenue
|
0.41
x
|
0.43
x
|
0.41
x
|
0.36
x
|
0.24
x
|
0.24
x
|
EV / Revenue
|
0.35
x
|
0.39
x
|
0.35
x
|
0.3
x
|
0.27
x
|
0.24
x
|
EV / EBITDA
|
3.04
x
|
3.5
x
|
2.81
x
|
3.53
x
|
8.09
x
|
2.58
x
|
EV / FCF
|
-357
x
|
34.7
x
|
14.6
x
|
10.3
x
|
-3.78
x
|
4.07
x
|
FCF Yield
|
-0.28%
|
2.88%
|
6.84%
|
9.72%
|
-26.4%
|
24.6%
|
Price to Book
|
0.51
x
|
0.53
x
|
0.49
x
|
0.46
x
|
0.37
x
|
0.32
x
|
Nbr of stocks (in thousands)
|
1,522,742
|
1,522,742
|
1,522,742
|
1,522,742
|
1,522,742
|
1,522,742
|
Reference price
2 |
0.0958
|
0.1001
|
0.0967
|
0.0911
|
0.0704
|
0.0621
|
Announcement Date
|
4/17/19
|
4/15/20
|
4/16/21
|
4/14/22
|
4/20/23
|
4/17/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
356.8
|
357.9
|
360.7
|
382.4
|
451
|
386.2
|
EBITDA
1 |
40.71
|
40.08
|
44.56
|
32.09
|
15.14
|
35.31
|
EBIT
1 |
22.27
|
19.83
|
26.5
|
14.4
|
-2.643
|
14.02
|
Operating Margin
|
6.24%
|
5.54%
|
7.35%
|
3.77%
|
-0.59%
|
3.63%
|
Earnings before Tax (EBT)
1 |
22.01
|
19.81
|
22.02
|
15.01
|
-4.197
|
10.35
|
Net income
1 |
14.28
|
15.56
|
16.65
|
11.01
|
-4.386
|
6.986
|
Net margin
|
4%
|
4.35%
|
4.62%
|
2.88%
|
-0.97%
|
1.81%
|
EPS
2 |
0.009381
|
0.0102
|
0.0109
|
0.007199
|
-0.002880
|
0.004587
|
Free Cash Flow
1 |
-0.3458
|
4.037
|
8.563
|
11.01
|
-32.41
|
22.34
|
FCF margin
|
-0.1%
|
1.13%
|
2.37%
|
2.88%
|
-7.19%
|
5.79%
|
FCF Conversion (EBITDA)
|
-
|
10.07%
|
19.22%
|
34.32%
|
-
|
63.28%
|
FCF Conversion (Net income)
|
-
|
25.94%
|
51.43%
|
99.99%
|
-
|
319.83%
|
Dividend per Share
2 |
0.005630
|
0.006140
|
0.006560
|
0.004340
|
-
|
0.004588
|
Announcement Date
|
4/17/19
|
4/15/20
|
4/16/21
|
4/14/22
|
4/20/23
|
4/17/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
15.3
|
-
|
Net Cash position
1 |
22.3
|
12.3
|
22.1
|
25.3
|
-
|
3.64
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
1.01
x
|
-
|
Free Cash Flow
1 |
-0.35
|
4.04
|
8.56
|
11
|
-32.4
|
22.3
|
ROE (net income / shareholders' equity)
|
6.11%
|
5.43%
|
5.66%
|
3.66%
|
-1.48%
|
2.39%
|
ROA (Net income/ Total Assets)
|
3.83%
|
3.36%
|
4.38%
|
2.32%
|
-0.42%
|
2.22%
|
Assets
1 |
372.8
|
462.9
|
380
|
474.7
|
1,056
|
314.8
|
Book Value Per Share
2 |
0.1900
|
0.1900
|
0.2000
|
0.2000
|
0.1900
|
0.1900
|
Cash Flow per Share
2 |
0.0200
|
0.0300
|
0.0300
|
0.0400
|
0.0300
|
0.0200
|
Capex
1 |
23.6
|
16.6
|
35.6
|
11.4
|
11.4
|
8.95
|
Capex / Sales
|
6.62%
|
4.63%
|
9.88%
|
2.98%
|
2.53%
|
2.32%
|
Announcement Date
|
4/17/19
|
4/15/20
|
4/16/21
|
4/14/22
|
4/20/23
|
4/17/24
|
|
1st Jan change
|
Capi.
|
---|
| +9.28% | 103M | | +5.14% | 103B | | -5.63% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.24B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +16.93% | 14.96B | | +7.73% | 15.03B |
Other Commodity Chemicals
|